Book a demo

Chemical intelligence powered by cypris.ai

Spinosad

(1S,2S,5R,7S,9S,10S,14R,15S,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione;(1S,2R,5S,7R,9R,10S,14R,15S,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione · also: Success · Natroba · Spintor · Natrova · Conserve · Comfortis

FormulaC83H132N2O20
Mol. weight1477.963
PubChem CID17754356
InChIKeyJFLRKDZMHNBDQS-SGSTVUCESA-N
SMILESCC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3[C@@H]2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C
20,418Patents
605Research papers609 indexed in detail
2,646Patents - last 3 years
50Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Bayer AG3,832
2BASF SE2,806
3Sinochem Holdings Corp Ltd2,449
4Corteva Inc1,986
5Sumitomo Chemical Co Ltd785
6FMC Corp461
7C.H. Boehringer Sohn AG and Co KG365
8Nippon Soda Co Ltd267
9Adeka Corp266
10MPM Holdings Inc208

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A01NPreservation of bodies; biocides; pest repellents16,589
2C07DHeterocyclic compounds9,133
3A61PTherapeutic activity (drug indications)4,775
4A01PBiocidal activity of chemical compounds2,806
5A61KMedicinal preparations2,731
6C12NMicroorganisms, enzymes1,895
7Y02AClimate change adaptation1,873
8C07CAcyclic and carbocyclic compounds1,848
9C07KPeptides1,065
10C07FOrganometallic compounds705

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Representative patents

The filings that best characterise the patent activity around this compound, most-referenced first.

TitleYearAssigneeCited by
Spinosad derivatives, preparation method thereof, and application of spinosad derivatives used as insecticide201117
Agricultural insecticidal composition containing spinosad and ZJ40422013Sinochem Holdings Corp Ltd16
Process for preparing spinosad201016
Method for preparing biological pesticide spinosad microcapsule preparation201015
Insecticidal composition containing spinosad and emamectin-benzoate200814

How research activity has moved

Papers published per year for this compound, over the last decade of indexed records.

YearPapers
201635
201730
201826
201935
202019
202118
202215
202312
202418
202520

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Guy SmaggheGhent University9
2Philip BatterhamThe University of Melbourne8
3Carlos F. MarinaInstituto Nacional de Salud Pública8
4Trent PerryThe University of Melbourne8
5Scott WisemanEli Lilly (United Kingdom)8
6J. Guillermo BondInstituto Nacional de Salud Pública7
7Neil W. MillerDaniel K. Inouye U.S. Pacific Basin Agricultural Research Center7
8Thomas C. SparksCorteva (United States)7
9Daniel E. SnyderElanco (United States)7
10Michael KristensenAarhus University6

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular composition of Spinosad?

Spinosad has the molecular formula C83H132N2O20 with a molecular weight of 1477.963. It is a mixture of two spinosyn components with distinct stereochemistry, as indicated by its canonical name containing two separate structural descriptions.

Which companies hold the most patents related to Spinosad?

The leading patent assignees in the Spinosad field are Bayer AG with 3832 patents, BASF SE with 2806 patents, and Sinochem Holdings Corp Ltd with 2449 patents. Other significant holders include Corteva Inc with 1986 patents and Sumitomo Chemical Co Ltd with 785 patents.

What is the primary research focus of published work on Spinosad?

The most cited papers on Spinosad focus on insect-plant interactions and control strategies. Key research areas include monitoring resistance in target insects such as diamondback moth and Colorado potato beetle, characterizing cross-resistance to other insecticide classes, and assessing non-target impacts on beneficial arthropods.

What are the main patent classification areas for Spinosad-related intellectual property?

Spinosad patents are predominantly classified under A01N (pesticide technologies) with 16589 patents, followed by C07D (organic compounds) with 9133 patents, A61P (medicinal chemistry applications) with 4775 patents, and A01P (agricultural pesticide applications) with 2806 patents.

How has patent activity for Spinosad evolved in recent years?

Patent filings related to Spinosad show fluctuation over the last decade, with notable peaks in 2021 (1236 patents) and 2024 (1295 patents). In the last three years, there were 2646 total patents filed, while academic paper output has remained relatively modest with 50 papers in the same period.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial